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Theubiquitously expressed largeGTPaseDynamin2 (DNM2)playsacritical role in the regulationof intracellular
membrane trafficking through its crucial function inmembrane fission, particularly in endocytosis. Autosomal-
dominant mutations in DNM2 cause tissue-specific human disorders. Different sets of DNM2mutations are
linked to dominant intermediate Charcot–Marie–Tooth neuropathy type B, a motor and sensory neuropathy
affecting primarily peripheral nerves, or autosomal-dominant centronuclear myopathy (CNM) presenting with
primary damage in skeletal muscles. To understand the underlying disease mechanisms, it is imperative to de-
termine towhich degree the primary affected cell types require DNM2. Thus, we used cell type-specific gene ab-
lation toexamine theconsequencesofDNM2 loss inskeletalmusclecells, themajor relevantcell type involved in
CNM. We found that DNM2 function in skeletal muscle is required for proper mouse development. Skeletal
muscle-specific loss of DNM2 causes a reduction in muscle mass and in the numbers of muscle fibers, altered
muscle fiber size distributions, irregular neuromuscular junctions (NMJs) and isolated degenerating intramus-
cularperipheralnervefibers. Intriguingly, a lackofmuscle-expressedDNM2triggersan increaseof lipiddroplets
(LDs) andmitochondrial defects.Weconclude that loss ofDNM2 function in skeletalmuscles initiates a chain of
harmful parallel and serial events, involving dysregulation of LDs and mitochondrial defects within altered
muscle fibers, defective NMJs and peripheral nerve degeneration. These findings provide the essential basis
for further studies on DNM2 function and malfunction in skeletal muscles in health and disease, potentially in-
cluding metabolic diseases such as diabetes.
INTRODUCTION
Multiple autosomal-dominant missense and short deletion
mutations have been identified in the Dynamin 2 (DNM2)
locus. Distinct groups of mutations are associated with domi-
nant intermediate Charcot–Marie–Tooth neuropathy type B
(DI-CMTB) or autosomal-dominant centronuclear myopathy
(CNM) (1,2). While DI-CMTB affects axons and myelinating
Schwann cells of peripheral nerves, CNM caused by mutations
inDNM2 (DNM2-CNM) is characterized by slowly progressive
muscular weakness with abnormal centralization of nuclei in
myofibers, radial arrangement of sarcoplasmic strands, type I
fiber predominance and small fiber sizes (3,4). How the different
DNM2mutant proteins lead to distinct diseases, affecting differ-
ent cell types as specific primary targets, is largely unclear. In
DI-CMTB, defective endocytosis is likely to be critical (2),
while impairment of autophagy might be a significant contribu-
tor in DNM2-CNM (5). Special effects on flawed membrane re-
modeling may be a common underlying feature (6). A major
progress on these crucial issues is expected to come from
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improved understanding of the normal physiological function of
DNM2 and its malfunctions in disease, on the molecular, cellu-
lar, tissue, organ and organism levels.
Molecularly, DNM2 belongs to the classical dynamins com-
prising DNM1 (mainly expressed by neurons), DNM2 (ubiqui-
tously expressed) and DNM3 (expressed mainly in brain and
testes) (7). These cytosolic proteins are large GTPases that act
mechano-chemically tomediate membrane fission. At the cellu-
lar level related to this function, classical dynamins regulate a
plethora of crucial processes, including endocytosis and intra-
cellular membrane trafficking in an interplay with the cytoskel-
eton.Extensiveworkhasprovidedawealth of informationon the
structure–function relationship of dynamins (7,8). Classical
dynamins have a well-conserved N-terminal GTPase domain,
a middle domain (MD) important for oligomerization and
a pleckstrin-homology (PH) domain that binds phosphoinosi-
tides, followed by a GTPase effector domain. The C-terminal
proline-rich domain coordinates dynamin function byphysically
interacting with various SH3 domain-containing proteins.
DNM2 mutations associated with DI-CMTB are clustered in
theN-terminal part of the PHdomain,whileDNM2-CNMmuta-
tions are predominantly found in the C-terminal region of the
same domain and in the MD (2,5). Biochemically, altered
GTPase activity (9) and formation of abnormally stable poly-
mers have been reported for some DNM2-CNM mutants (10).
In contrast, selected CMT-associated DNM2 mutants show
reduced binding to membranes (11).
On the tissue level and in organisms,mousemodels carrying a
Dnm2-CNMmutation [Knock-in R465W (1,5)], or viral-vector-
mediated overexpression of DNM2 wild-type or the R456
mutant proteins (12), revealed variable muscle dysfunctions
associated with mitochondrial, proteasomal and autophagy
defects. Consistent with these data, mice lacking miRNA 133a
and consequently overexpressing its Dnm2 target, developed a
CNM-like phenotype (13). Expression knockdown of dnm2
and dnm2-like, the putative DNM2 orthologs in zebrafish,
resulted in extensivemorphological abnormalities during devel-
opment (14).
We found that mice carrying a ubiquitous heterozygous dele-
tion of Dnm2 have no detectable phenotype up to the age of 15
months, the last time point examined (unpublished data).
These results strongly indicate that disease-causing DNM2
mutations (these mutations are all dominantly inherited) are
not loss-of-function mutations causing disease due to DNM2
haploinsufficiency, but rather act by gain-of-function or
dominant-negativemechanisms. This raises the important ques-
tion whether skeletal muscles are fundamentally dependent on
DNM2 function. We tested this issue using ablation of Dnm2
specifically in mouse skeletal muscles. Our data show that
DNM2 function in muscle is strictly required for proper mouse
development.
RESULTS
DNM2 function in skeletal muscle is required for proper
mouse development
In this study, we have used a conditional mouse null allele for
Dnm2 (Dnm2fl) that was generated by flanking exon 2 with
LoxP sites using homologous recombination and standard
embryonic stem cell technology (2). To assess whether DNM2
function in skeletalmuscle is required for propermousedevelop-
ment, we bred mice carrying the Dnm2fl allele with an estab-
lished mouse line that expresses Cre recombinase specifically
in skeletalmuscle cells [HSACre (15)]. The experimental breed-
ing (HSACre Dnm2fl/+×Dnm2fl/fl) yielded the expected geno-
types in the Mendelian ratio. To confirm tissue-specific loss of
DNM2 in HSACreDnm2fl/fl mice, we analyzed protein lysates
from gastrocnemius muscle at postnatal day (P) 5 and P10 by
western blotting. As expected, DNM2 levels were strongly
reduced in HSACreDnm2fl/fl mutants compared with control
lysates (Fig. 1A). Residual amounts of DNM2 are likely
mainly due to DNM2-expressing, non-targeted muscle-resident
cells including Schwann cells, fibroblasts and satellite cells.
Next, we reasoned that other functionally similar members of
the classical dynamin protein family might be aberrantly regu-
lated in the absence of DNM2 as part of potential compensatory
mechanisms. In line with this hypothesis, we found that DNM1
expression was increased in HSACreDnm2fl/fl mice-derived
gastrocnemius muscle lysates compared with controls, both at
P5 and at P10, while DNM3 levels were not altered (Fig. 1A).
HSACreDnm2fl/flmicewere generallyweaker than their litter-
mates and became moribund between P11 and P14. We found
that the body weight of HSACreDnm2fl/fl mutants was signifi-
cantly decreased compared with controls already at P5 and
even more strikingly at P10 (Fig. 1B and E). Determining the
ratios between the weight of the gastrocnemius muscle or the
diaphragm muscle and the body weight revealed significant
reductions at P5 and P10 in mutants versus controls (Fig. 1C
and D), consistent with loss of muscle mass. Qualitative inspec-
tions revealed a similarly decreased mass of other muscles,
including the gluteus muscle, the tibialis muscle and the quadri-
ceps muscle.
Skeletal muscles are dependent on DNM2 function
The observed decrease in the muscle mass of HSACreDnm2fl/fl
mice suggests a skeletal muscle defect. The main factors that
may contribute to this finding are muscle fiber loss, muscular
hypotrophy or atrophy and/or a delay in muscle development.
To address this issue, we examined first the muscle morphology
on hematoxylin/eosin-stained cross-sections of gastrocnemius
muscles. Already at P5, the muscles of HSACreDnm2fl/fl mice
were grossly abnormal (Fig. 2A).Mutantmuscle fibers appeared
to be slightly larger than in control mice, defective fibers
were present and the interstitial space was enlarged, leaving
the impression of a decreased muscle fiber density compared
with controls.AtP10, damagedmusclefibers dominated inHSA-
CreDnm2fl/fl mice, and Masson trichrome staining revealed a
minor increase in collagen comparedwith controls (Supplemen-
tary Material, Fig. S1).
To address whether the alteredmorphology results from aber-
rant cell survival and/or from a delay in muscle cell maturation,
weanalyzedfirst cell death and cell proliferation.TUNELassays
on cross-sections of P5 and P10 gastrocnemius muscles from
HSACreDnm2fl/fl mice and controls revealed increased cell
death in mutants at both time points (Fig. 2B). Parallel prolifer-
ation analyses using short-termBrdU injections and appropriate
staining techniques revealed a modest increase in cell prolifer-
ation in HSACreDnm2fl/fl mice compared with controls at P5,
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contrasting with a decrease in proliferation in mutants versus
controls at P10 (Fig. 2C).
The observed early changes in cell proliferation and cell death
might be interpreted as alterations in the maturation status of
muscles lackingDNM2.Toexamine thismatter,weusedananti-
developmental myosin heavy chain (dMHC) antibody recogniz-
ing embryonic and neonatal MHC isoforms that are downregu-
lated during muscle maturation. Cross-sections of P5 and P10
gastrocnemius muscles of HSACreDnm2fl/fl mice and controls
were stained for dMHC together with the fiber boundary
marker laminin g1. We found dMHC-positive fibers in both P5
mutant and control muscles without appreciable differences
(8.0+ 0.7% in controls and 8.2+ 0.9% in mutants, n ¼ 3;
Fig. 2D).Correspondingwestern blot analyses revealed compar-
able dMHC levels inmutant and controlmice at both P5 and P10
(Fig. 2E). As expected and validating the antibody reagent,
dMHC expression was lower at P10 compared with P5 (16),
while total MHC levels remained unchanged.
Based on the results obtained so far,we favored the hypothesis
thatmuscle atrophyand/or fiber loss aremajor contributors to the
pathology observed after loss of DNM2 in skeletal muscle. To
address this issue, we analyzed first the total number of muscle
fibers on hematoxilin/eosin-stained cross-sections of gastrocne-
mius muscles from P5 and P10 HSACreDnm2fl/fl mice and con-
trols. We found a decrease in the number of muscle fibers in
mutants compared with controls at both time points (Fig. 3A).
In the second step, we performed the corresponding ultrastruc-
tural analysis to evaluate muscle fiber size distributions. As sug-
gested previously by the hematoxilin/eosin staining (Fig. 2A), a
shift toward larger muscle fiber calibers was found in HSA-
CreDnm2fl/fl mice in comparison to controls at P5 (Fig. 3B). In
contrast at P10, we detected an increase in the proportion of
small caliber muscle fibers in HSACreDnm2fl/fl mice (Fig. 3C).
We conclude that Dnm2 ablation in skeletal muscle causes
alterations in fiber size, fiber atrophy and fiber loss.
Lack of DNM2 in skeletal muscles causes dysregulation
of LDs
Ultrastructural analysis of the gastrocnemius muscle of HSA-
CreDnm2fl/fl mice and controls revealed aberrant regulation
of lipid droplets (LDs) in mutants. Such droplets serve as
stores of metabolic energy andmembrane components, regulate
various cellular processes, and are linked to several pathological
Figure 1.Ablation of DNM2 in skeletal muscles impedes normal mouse development due to reducedmusclemass. (A)Western blot analysis of expression levels of
classical dynamins ingastrocnemiusmusclesofHSACreDnm2fl/flmutantmice (M)andDnm2fl/fl controls (C)at P5andP10. Inmutantanimals comparedwith controls,
Dnm2 levels are reduced,Dnm1 is upregulated andDnm3 expression is not altered. GAPDH served as a loading control. A representative blot out of five independent
experiments is shown. (B) Quantitative analysis of bodyweights in grams (g) of HSACreDnm2fl/fl andDnm2fl/flmice at P5 and P10 showing reduced bodyweights of
mutant animals compared with controls. (C) Analysis of the ratio between gastrocnemius muscle weight in milligrams (mg) and body weight in grams (g) of HSA-
CreDnm2fl/fl mutant mice and Dnm2fl/fl controls at P5 and P10 revealing reductions in mutants compared with controls, consistent with reduced muscle mass. (D)
Analysis of the ratio between diaphragm muscle weight in milligrams (mg) and body weight in grams (g) of HSACreDnm2fl/fl mutant mice and Dnm2fl/fl controls
at P5 and P10 shows reductions inmutants comparedwith controls, consistentwith the reducedmusclemass. At least 14 animals of each genotype and developmental
agewere included in theanalyses in (B)and (C).Threeanimalspergenotypeanddevelopmental agewere included in theanalyses in (D). (E)Representativepicturesof
HSACreDnm2fl/fl mutant mice and Dnm2fl/fl controls at P5; ∗P , 0.05, ∗∗P , 0.01, ∗∗∗P, 0.001.
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conditions (17). At P5, we found both an increased LD density
and an increased area thatwas occupied byLDs in the gastrocne-
mius muscle of HSACreDnm2fl/fl mice compared with controls
(Fig. 4A and C). These findings were qualitatively confirmed
using Oil red O stainings (Fig. 5). In contrast at P10, the
densityofLDswasdecreased inHSACreDnm2fl/flgastrocnemius
muscles comparedwith controls (Fig. 4B andD). At this age, the
analysis also revealed a trend toward a smaller area occupied by
LDs in the mutants, but the difference did not reach statistical
significance (Fig. 4D). LDs are often associated with other orga-
nelles including endosomes and mitochondria (17). Further-
more, DNM2 regulates various aspects of endosome biology
and interacts with the cytoskeleton (7). Thus, we evaluated
whether lack of DNM2 influences the position of LDs inside
muscle fibers. We counted LDs that did not contact the sarco-
lemma (inside fiber) and those that contacted the sarcolemma
(border fiber). No major differences were found between HSA-
CreDnm2fl/fl gastrocnemius muscles and controls at P5 and
P10, although there was a minor increase in the portion of LDs
contacting the sarcolemma at P10 in the mutants (Fig. 4E and
F). Furthermore, at P5 we found a significant increase in the
density of LDs forming clusters in mutant muscles compared
with controls (arrowheads in Fig. 4A, Supplementary Material,
Fig. S2).
Tocharacterize the intriguingDNM2-dependentLDalterations
further, we evaluated the localization and levels of two proteins.
Adipocyte differentiation-related protein (ADRP-adipophilin)
was chosen due to its prominent localization to LD membranes
Figure 2.Deficient structures, increased cell death and altered proliferation in muscles lacking DNM2. (A) Hematoxylin/eosin stainings of cross-sections of gastro-
cnemiusmuscles ofHSACreDnm2fl/flmutantmice andDnm2fl/fl controls at P5 andP10.Damagedfibers (arrowheads) are plentiful inmutants.At least four animals of
each genotype and age have been analyzed and representative pictures are shown. Scale bars ¼ 20 mM. (B) Quantification of cell death in gastrocnemius muscle by
TUNEL.The ratiosbetween thenumberof apoptotic cells (TUNELpositive) and total numberof nuclei are increased inmutant animals comparedwith controls at both
P5 and P10. (C) Proliferation in the gastrocnemius muscle, as determined by the ratio between BrdU-positive nuclei versus total number of nuclei, is increased in
mutants compared with control mice at P5 and decreased at P10. In (B) and (C), three animals were analyzed and at least 1000 nuclei per animal counted; ∗P ,
0.05, ∗∗P , 0.01. (D) Single-plane confocal microscopy sections of tissue cross-sections of gastrocnemius muscles of P5 mice, stained for laminin g1 (green) and
dMHC(red) expression. A representative picture out of three independent experiments is shown. Scale bar ¼ 25 mM. (E) Western blot analysis of dMHC and
MHC levels of gastrocnemius muscles shows no differences between mutants and controls at P5 or P10. GAPDH served as a loading control. A representative
blot out of four independent experiments is depicted.
4420 Human Molecular Genetics, 2013, Vol. 22, No. 21
(18). Caveolin 3 was selected since caveolin can be localized to
LDs under various experimental, but also physiological condi-
tions (17). Furthermore, caveolin 3 plays a crucial role in the
proper assembly of caveolae at the plasma membrane in skeletal
muscle as highlighted by various skeletal muscle diseases due to
caveolin 3 defects (limb–girdle muscular dystrophy, rippling
muscle disease, distal myopathy and hyperCKemia (19)). Cross-
sections of gastrocnemius muscles, collected at P5 and P10
fromHSACreDnm2fl/flmice and controls, were stained for adipo-
philin or caveolin 3 in combination with the fiber boundary
marker laminin g1. Compared with control animals, adipophilin
staining was much more abundant within muscle fibers of
mutant mice at P5 (Fig. 6A) and remained increased at P10
(Fig. 6B). Consistent with these immunohistochemical findings,
western blot analysis revealed that adipophilin protein levels
were also increased in mutants compared with controls, both at
P5 and at P10 (Fig. 6E). Caveolin 3 staining revealed noparticular
localization within the core of gastrocnemius muscle fibers of
HSACreDnm2fl/fl and control mice (Fig. 6C and D). However,
caveolin 3 distribution was disorganized at the muscle fiber
plasma membrane in mutants (Fig. 6C and D) and caveolin
3 protein levels were increased compared with controls, both at
P5 and at P10 (Fig. 6C, D and F). We consider it likely that
these findings are secondary consequences of the observed
muscle fiber abnormalities due to lack of DNM2. Along these
lines,wealsofoundmassiveaccumulationsofhighlyubiquitinated
proteins and an upregulation of the lysosomal marker LAMP1 in
DNM2nullmuscles (SupplementaryMaterial, Fig. S3), consistent
with an impairment of degradative properties of the proteasomal/
lysosomalpathways.Taken together, theseresults indicatean intri-
guing and obligatory link between DNM2 function and various
lipid-regulated events in skeletal muscle.
DNM2 in skeletal muscle is required for proper
mitochondrial morphology and function
LDs interact with mitochondria and offer them the substrate
for b-oxidation to generate energy (18). Thus, we examined
mitochondria in mouse skeletal muscles lacking DNM2.
Morphologically, mitochondrial shapes (Fig. 7A and B) and
sizes (Fig. 8D) appeared to be normal in gastrocnemius
muscles of HSACreDnm2fl/fl mice compared with controls at
P5. However, the density of mitochondria was reduced in
mutants (Fig. 8A). In P10 mutants, we found a similar reduction
(Fig. 8B), but in striking contrast to the findings at P5, there was
also a remarkable disruption of the mitochondrial morphology,
particularly affecting mitochondrial cristae (Fig. 7C and D). In
addition, the size of mitochondria was altered with a marked
shift toward larger mitochondria in mutants (Fig. 8E). To
examine whether the observed morphological variations corres-
pond to alterations in the respiratory chain of mitochondria, we
analyzed protein expression levels of the 39 kDa subunit of the
respiratory complex I (CI) and of the 70 kDa subunit of the re-
spiratory complex II (CII), both located in the inner mitochon-
drial membrane in gastrocnemius muscles. Additionally, we
measured VDAC1 (porin) protein expression as a marker of
the outer mitochondrial membrane. CI and CII were decreased
at P5 and P10 inHSACreDnm2fl/flmice compared with controls,
whileVDAC1wasunaltered (Fig. 8C). In summary, these results
demonstrate that DNM2 is required in skeletal muscle to assure
correct mitochondria numbers, structure and function.
DNM2 in skeletal muscle is required for proper
neuromuscular junctions and peripheral nerve stability
In some pathological conditions (20,21), alterations of muscle-
resident mitochondria correlate with the aberrant structure and
function of the neuromuscular junction (NMJ). Furthermore,
Figure 3.Reduced numbers and altered size distributions of muscle fibers due to
DNM2 deficiency. (A) Quantitative analysis of fiber numbers of gastrocnemius
muscles of HSACreDnm2fl/fl mutant mice and Dnm2fl/fl controls at P5 and P10
reveals decreases inmutants. (B) Analysis of fiber distributions in gastrocnemius
muscle at P5 and (C) at P10 in mutants versus control mice. Note the increase in
the portion of large caliber fibers inmutants at P5,while there is an increase in the
small caliber fiber portions at P10. Three animals were analyzed for each geno-
type and developmental age; ∗P , 0.05, ∗∗∗P, 0.001.
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proper protein transport and clustering of acetylcholine re-
ceptors (AChRs) in the sarcolemma are crucial for correctly
structured NMJs. Given the mitochondrial deficiencies inHSA-
CreDnm2fl/flmice and the knownpleiotropic functions ofDNM2
in the regulation of endosomes and the cytoskeleton, we asked
whether NMJs require DNM2 in skeletal muscle. Since the dia-
phragm was also affected, we examined this issue by preparing
whole mount diaphragm muscles from P5 HSACreDnm2fl/fl
Figure 4. Lack of DNM2 causes dysregulation of LDs in skeletal muscle (electron microscopy analysis). Ultrathin sections of gastrocnemius muscles of HSA-
CreDnm2fl/fl mutant mice and Dnm2fl/fl controls at P5 (A) and P10 (B) analyzed by electron microscopy. Exemplary LDs are marked by asterisks in (A) and with
an additional arrow in (B). Cluster formation of LDs is highlighted by arrowheads. Scale bars ¼ 5 mM. (C and D) Quantitative analysis of the number of LDs per
muscle area and of the ratios between the area occupied by LDs and the muscle area is depicted for mutants and controls at P5 and P10. (E and F) Analyses of ld
localizations are shown in mutant and control muscles at P5 and P10. LD localizations have been distinguished as inside fiber (localized in the core of the fibers)
or border fiber (touching the sarcolemma). Three animals were analyzed for each genotype and developmental age; ∗P , 0.05, ∗∗P , 0.01.
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mice and controls. AChRs were identified using incubation with
labeled alpha-bungarotoxin and axons were labeled with
antibody-based neurofilament staining. Analysis by confocal
microscopy revealed increased sizes of neuromuscular end-
plates in mutant mice compared with controls, with diffusely
organized AChR in mutants (Fig. 9A and B). We conclude that
lack of DNM2 in muscles alters NMJs and may affect normal
clustering of AChRs.
Next, we hypothesized that the observed muscle and NMJ
alterations may also affect nerve integrity. Thus, we analyzed
the morphology of intramuscular nerves of HSACreDnm2fl/fl
mice and controls at P10. Remak bundles appeared in a regular
shape and axons were normally myelinated in mutant mice,
but there were frequent signs of axonal degeneration (Fig. 9C
and D; 4.68+ 0.16% axons affected in mutants versus 0.86+
0.02% in controls; n ¼ 3 mice; at least 2000 axons counted in
each condition). Thus, the dependence of skeletal muscles on
DNM2 is propagated to cause axonal degeneration in peripheral
nerves, rendering them indirectly dependent on skeletal-muscle
expressed DNM2. Mitochondria dysfunction in the muscle
and defective NMJ are likely to contribute to this chain of dele-
terious events.
DISCUSSION
Twodisorders are associatedwithmutations in the gene encoding
the largeGTPaseDNM2.Primarily peripheral nerves are affected
in DI-CMT, while skeletal muscles are primarily affected in
CNM. Both diseases are dominantly inherited. Studies aimed
at determining the underlying disease mechanisms in various
transgenic mice and cell culture models revealed predominantly
gain-of-functions and/or dominant-negative effects of mutant
DNM2 proteins. However, partial loss-of-function has also been
suggested for aparticularDNM2mutantwithaveryseverepheno-
type in the homozygous state (22). To elucidate this issue further
and todetermine thenecessityofDNM2innormalphysiology,we
used gene targeting in the mouse. An ubiquitous loss of DNM2
turned out to be embryonically lethal at an early developmental
stage [our unpublished data (23)]. This finding precluded further
analyses of muscles, our intended primary focus in this study
based on the key role of this tissue in DNM2-CNM. Thus, we
resorted to a conditional Dnm2fl/fl allele (2), in combination with
cell type-specific Cre recombinase expression, to eliminate
DNM2 specifically from skeletal muscle cells in vivo. We found
that DNM2 expression in skeletal muscles is an obligatory pre-
requisite for accurate mouse development. Specific analyses
revealed that DNM2 function is required for correct muscle
fiber numbers, sizes and survival. Mitochondria and proper regu-
lation of lipid metabolism, in particular the dynamics of LDs, are
dependentonDNM2.Furthermore,wefound thatmuscle-specific
loss of DNM2 caused enlargements of neuromuscular endplates
accompanied by axonal damage in intramuscular nerves.
As expected from the analysis of heterozygous Dnm2
null mice, we did not detect a phenotype in mice carrying a
muscle-specific heterozygous Dnm2 deletion (data not shown).
This finding allowed us to focus our analyses on mice lacking
DNM2 in muscle cells. As most obvious features, these
animals had decreased muscle mass, loss of muscle fibers and
severe alterations in muscle morphology early in postnatal life.
Our examinations indicate that the observed myopathy is
likely due to loss of muscle fibers, in combination with atrophic
fibers, rather than a delay in fibermaturation. The defects caused
general weakness and death of the animals around P14.
Figure 5. Effects of DNM2 ablation on LDs in skeletal muscle (histological analysis). Oil red O staining for LDs of (A) P5 and (B) P10 sections of gastrocnemius
muscles of HSACreDnm2fl/fl mutant and control mice. Three animals have been analyzed and representative pictures are shown. Scale bar ¼ 30 mM.
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Consequently,we restricted our analyses to timepoints up toP10
on animalwelfare grounds. Analyses of long-term effects of loss
of DNM2 in muscle will require the development of suitable
hypomorphic Dnm2 alleles, or targeting the loss of DNM2 to
specific muscle groups using appropriate germline transgenic
methods or viral vector-based approaches.
Ablation of DNM2 in skeletal muscle cells caused a strong in-
crease in LDs in muscles at P5. LDs contain neutral lipids and
regulate their storage and hydrolysis. In doing so, LDs store
metabolic energy and membrane components (17). Further-
more,LDsaremotile andappear to interactwith the endoplasmic
reticulum, endosomes, peroxisomes andmitochondria indistrib-
uting lipids to those organelles (24). These processes include
vesiculation in response to metabolic demands and can depend
on the vesicle scission activity of the dynamin mechanoenzyme
(Susan Chi and Marc McNiven, personal communication). It
appears to be plausible that disturbances of these physiologically
important activities contribute to our observation of increased
LDs in DNM2-deficient muscle cells. Since the levels of fatty
acid synthase (FASN), the key enzyme involved in the synthesis
of fatty acids, are not altered in DNM2-deficient muscles at P5
or P10 (Supplementary Material, Fig. S3C), increased cell-
autonomous lipogenesis is unlikely to be a major contributor
to the increased LDs. However, LD build-up due to altered cell
metabolism remains to be considered since LD accumulation
in muscles can be induced through treatment with toxic sub-
stances [Fialuridine (25), Zidovudina (26)] and is found in
pathological states such as diabetes, atherosclerosis and meta-
bolic disorders (27,28). Whether and to which degree these
pathological states are interconnected with the regulation of
DNM-mediated LD dynamics remains a challenging question
for the future.
One suggested function of LDs is providing lipids to mito-
chondria for ß-oxidation (29). Generally, LDs andmitochondria
are found in close apposition inside the cells. Furthermore, the
SNARE family protein SNAP23 plays an important role in
LD fusion (30,31) and in generating LD-mitochondrial com-
plexes, affecting ß-oxidation and possibly involving fusion of
LDs with mitochondria (32). Indeed, such a close association/
fusion may explain our surprising observation of numerous
structures that were positive for the LD marker adipophilin in
DNM2-deficient muscles at P10, when LDs were not increased
anymore compared with control muscles. In the context of the
close structural and functional association between LDs and
mitochondria, it is remarkable that ablation of DNM2 in skeletal
muscle cells in our studywas correlatedwithmassivemitochon-
dria enlargements and disruptions of cristae at P10. In addition,
expression of subunits of the respiratory complexes I and II was
reduced already at P5, indicating early negative physiological
consequences of DNM2 loss on mitochondria.
Swollen mitochondria harboring disorganized cristae have
also been observed in a mouse model of diabetes, and LD accu-
mulation and mitochondrial dysfunction are typically detected
in insulin resistance type 2 diabetic mice (20,33,34). Insulin re-
sistance is a hallmark of type 2 diabetes and is also found in
patients affected by insulin-resistant syndrome or dysmetabolic
syndrome (35). Cell culture experiments have shown that ex-
pression of DNM-K44A results in specific alterations of the
insulin receptor signaling pathway by inhibiting clathrin-
mediated endocytosis of the insulin receptor in adipocyte, result-
ing inan increasedbasal rate of glucoseuptake, glycogen synthe-
sis and lipogenesis (36). Comparing these findings and the
consequences of insulin resistance with our data in DNM2-
Figure6.DNM2ablation inmuscle cells causes increased expression and altered
localization of the LD-associated protein adipophilin and caveolin 3. Cross-
sections of gastrocnemius muscles of HSACreDnm2fl/fl mutant mice and
Dnm2fl/fl controls at P5 (A andC) and P10 (B andD) stained with antibodies rec-
ognizing laminin g1 (red) and adipophilin (green; A and B) or caveolin 3 (green;
C and D). Arrows in (C) and (D) indicate areas with accumulation of caveolin
3.Western blot analyses of gastrocnemius protein lysates frommutants and con-
trols at P5 and P10 show increased expression levels of adipophilin (E) and
caveolin 3 (F) in mutants (marked M) compared with controls (marked C). Pic-
tures and western blots are representative of three independent experiments.
Scale bar ¼ 15 mM.
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deficient muscles reveals interesting parallels and warrants
further investigations.
Altered NMJs are an additional feature in murine models of
diabetes (36) and recent data implicate NMJ abnormalities
also in DNM2-CNM (37). We found increased sizes of neuro-
muscular endplates in muscle-specific DNM2-deficient mice.
Thus, loss of DNM2 function in muscle is sufficient to severely
alter the morphology of NMJs, most likely affecting also their
physiology and contributing to the macroscopic phenotype of
the mice. This requirement of muscle-expressed DNM2 must
be taken into account if interpreting NMJ deficits in disease.
Given the multiple defects observed in muscles lacking
Figure 7.DNM2 deficiency inducesmorphological mitochondrial aberrations. Electronmicroscopy-derived pictures of ultrathin sections of gastrocnemius muscles
of HSACreDnm2fl/flmutant mice and Dnm2fl/fl controls at P5 (A) and P10 (C) are shown. Scale bars ¼ 5 mM. Square areas in (A) and (C) are enlarged in (B) and (D),
respectively, to highlight the swollen mitochondrial structure and disruption of cristae at P10. Arrowheads indicate mitochondria (B and D).
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DNM2, however, the direct course of events leading to NMJ
alterations remains largely speculative. Flawed mitochondrial
function may be involved (36). Another likely contribution
might come from altered AChR clustering. Lack of DNM2
could interfere with trafficking of proteins important for cluster-
ing and/or affect the biosynthesis and signaling of the AChR re-
ceptor (38). A potential regulatory role of LDs must also be
considered since LDs can serve as regulators of membrane bio-
genesis and may affect signaling.
An intriguingfinding in our studywas the damageof peripheral
nerves, secondary to restricted DNM2 deficiency inmuscles. It is
well known that development and maintenance of NMJs is a
dynamicprocess that involvesbothmusclesandnervesdepending
on each other. Muscle abnormalities in energy metabolism can
cause denervation (21) and thus, nerve damage in specifically
DNM2-deficientmusclesmight be due to the observedmitochon-
drial alterations. However, altered protein biosynthesis, metabol-
ism and/or trafficking that affect the NMJ may contribute by
affecting proper signaling from muscle to axon and provoking
axonal instability and degeneration.
Taken together, we demonstrate that DNM2 function in
muscle cells is an absolute requirement formuscles and, indirect-
ly, peripheral nerve biology. In addition to the well-known mo-
lecular functions of DNM2 as worked out in cell culture and by
biochemical approaches, we propose that lipid and energy me-
tabolism are key physiological processes that are regulated and
dependent on the proper function of this central large GTPase.
Our findings warrant particularly future investigations in the
functional roles of DNM2 in LD dynamics and its associated
regulatory processes. We anticipate that such studies will
provide important knowledge relevant todevelopnewapproaches
to tacklenotonlyCNMbutalso insulin resistance-like syndromes.
MATERIALS ANDMETHODS
Mice
Experiments followed approved protocols (Veterinary Office,
Canton Zurich, Switzerland). Mice carrying LoxP flanking
exon 2 of the DNM2 gene (2) were breed with mice carrying a
transgene encoding Cre recombinase under the control of
human skeletal actin (HSA) regulatory elements [(16); kind
gift of Dr Ulrich Mu¨ller, Scripps Research Institute, La Jolla,
USA]. Genotypes of mice were determined by polymerase
chain reaction on genomic DNA.
Electron microscopy
Anesthesia ofmicewas achievedwith an IP injection of 150 mg/
kg pentobarbital (Nembutal; Abbott Laboratories). Mice were
perfused with 1% heparin sodium in 0.1 M phosphate buffer
(pH 7.4), followed by 3% glutardialdehyde and 4% paraformal-
dehyde (PFA) in 0.1 M phosphate buffer. Fixed muscle tissues
were post-fixed in 2% osmium tetroxide, dehydrated via a
Figure 8.Quantification of DNM2 deficiency-inducedmitochondrial aberrations. Quantification of the density of mitochondria reveals a reduction in mutants com-
paredwith controls at P5 (A) and P10 (B).Whilemitochondrial size distribution is not altered inmutants at P5 (D), there is a strong shift toward largermitochondria in
themutants versus controls at P10 (E). Three animals have been analyzed for each genotype and developmental age. (C)Western blot analysis of selectedmitochon-
drial proteins in gastrocnemius protein lysates ofHSACreDnm2fl/flmutantmice andDnm2fl/fl controls at P5 andP10. Porin (VDAC1)was used as amarker of the outer
membrane. The 39 kDa subunit of theNADHubiquinone oxidoreductase of respiratoryCI and the 70 kDa subunit of the respiratory CIIwere employed asmarkers of
the inner mitochondrial membrane. GAPDH served as loading control. Representative western blots out of four independent experiments are shown; ∗P , 0.05,
∗∗P , 0.01.
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graded acetone series and embedded in Spurr’s resin (EMS as
described previously (39). Ultrathin sections were contrasted
with 3% uranyl acetate and 1% lead citrate before analysis in a
transmission electronmicroscope (FEIMorgagni 268, FEIElec-
tron Optics, The Netherlands).
Histochemical stainings
After dissection, muscles were frozen by immersion in liquid
nitrogen-cooled isopentan. Ten micrometer muscle sections
were cut on a cryostat and hematoxylin/eosin staining was
carried out as described (40). Masson’s trichrome staining (41)
was performed using a commercial kit (HT-15; Trichrome
Stain Kit; Sigma-Aldrich).
LDs and mitochondria
The size of LDs and mitochondria was evaluated using CS5
Photoshop analysis software.
Immunohistochemistry analysis
P5 and P10 gastrocnemius muscles were dissected from mice
of different genotypes and frozen through immersion in liquid
nitrogen-cooled isopentane. Ten micrometer sections were
obtained using a cryostat. The sections were permeabilized
and fixed according to the detecting antibody used. For dMHC
stainings, the sections were fixed for 10 min with 4% PFA,
washed three times in phosphate-buffered saline (PBS) and
blocked 1 h at room temperature in 20% goat serum, 2%
bovine serum albumin (BSA), 0.1% Triton in PBS. Sections
were then incubated with dMHC (Leica) and rat anti laminin
g1 (Millipore) over night at 48C. After three washes in PBS,
the sections were incubated with Cy3-conjugated anti-rabbit
(Jackson Laboratories, 1:500) and Alexa488-conjugated anti-
rat (Molecular Probes, 1:500) antibodies in blocking buffer for
1 h at room temperature, and washed with PBS. After 5 min in-
cubation with DAPI solution, the sections were washed and
mounted with IMMU-MOUNT (Thermo Fisher Scientific,
Germany).Adipophilin and caveolin3 stainingswere performed
as described (26). Antibodies used were rabbit anti-adipophilin
Figure 9.Ablation of DNM2 inmuscle leads to altered NMJs and axonal degeneration. 3D confocal reconstructions (A) of NMJ staining of whole mount diaphragm
muscles are shown. Neurofilament (red), bungarotoxin (green). (B) Quantification of the area occupied by AChR based on Z-stack confocal images of entire NMJ.
Three animals have been analyzed for each genotype with at least 20 NMJs measured per animal. (C andD) Electron microscopy-derived pictures of intramuscular
nerves show degenerated (arrowheads) and degenerating (arrow) axons in HSACreDnm2fl/fl mutants. ∗∗P , 0.01 (B and C) Scale bar ¼ 10 mM.
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(Abcam) and rabbit anti-caveolin 3 (Enzo Life Science). Images
were generated with a confocal inverted microscope (Leica
SP2-AOBS) using argon and helium/neon lasers and imported
to Adobe Photoshop CS5 for level adjustment, cropping and
merging. To analyze NMJs, whole mount diaphragm muscles
were dissected and freshly fixed in 4%PFA.After 30 min incuba-
tion with bungarotoxin-FITC (Molecular Probes), the tissue was
treated for 2 h with blocking buffer (PBT: 1% Triton X-100, 2%
BSA in PBS). Samples were incubated overnight with a primary
mouse antibody against neurofilament (Chemicon). After 10
washes in PBT, specimenswere incubated for 3 hwith secondary
antibodyantimouse-CY3antibodies inPBTat48C.Thenprepara-
tionswerewashed three times for30 min inPBT,once for5 min in
PBS and post-fixed for 10 min in 1% PFA. Finally, samples were
mounted and analyzed by confocal microscopy.
Oil red O
Three parts ofOil redO stock solution (0.5%Oil redO in isopro-
panol)weredilutedwith twoparts ofH2O.Muscle sections, fixed
for 1 h at room temperature using 3.7% formaldehyde solution,
were rinsed three times for30 s inH2O, immersed in theOil redO
working solution for 30 min, rinsed with H2O for 10 min and
mountedwith IMMU-MOUNT (Thermo Fisher Scientific) (42).
Western blot analysis
Gastrocnemius muscles were dissected and frozen in liquid ni-
trogen. Muscle samples were placed in a dry ice pre-cooled
metal pestle and homogenized. The generated powder was col-
lected and re-suspended in 250 ml lysis buffer (95 mM NaCl,
25 mM Tris–Cl pH 7.4, 10 mM EDTA, 2% SDS, 1:100 protease
inhibitor, 1:100 NaF, 1: 100 Na2V3). Samples were sonicated
twice for 5 min, with vortexing in between, boiled for 5 min
and centrifuged for 5 min. Supernatants were collected and
protein quantification was performed with the Piercew BCA
Protein Assay kit (Thermo scientific). Fifteen micrograms
of protein lysates were then analyzed by standard blotting techni-
ques. Signals were quantified using Fusion Fx7 Image J software.
Antibodies used: rabbit anti-Dnm1 (Abcam), rabbit anti-Dnm2
(2), rabbit anti-Dnm3 (Abcam), rabbit anti-dMHC (Leica),
rabbit anti-MHC (Cell Signaling), rabbit anti-adipophilin
(Abcam), rabbit anti-caveolin 3 (Enzo Life Science), mouse
anti-ubiquitin (Santa Cruz), rat anti-LAMP1 (DSHB), rabbit anti-
FASN (Abcam), mouse anti-VDAC1 (Abcam), mouse anti-
subunit 39 kDa Complex1 (Molecular Probes) and mouse
anti-subunit 70 kDa Complex 2 (Molecular Probes).
Statistical analysis
Data represent the average and the standard error of the mean
of at least three independent experiments if not indicated differ-
ently. Statistical analysis was performed via a two-tailed Stu-
dent’s t-test.
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